This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Iscotrizinol
- DrugBank Accession Number
- DB15468
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Iscotrizinol (DB15468)
- Weight
- Average: 766.0
Monoisotopic: 765.457768028 - Chemical Formula
- C44H59N7O5
- Synonyms
- Iscotrizinol
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Calming Days Vegan Sunscreen Iscotrizinol (1.2 g/100mL) + Bisoctrizole (2 g/100mL) + Diethylamino hydroxybenzoyl hexyl benzoate (3 g/100mL) + Octyl triazone (2.4 g/100mL) Gel Topical Merci Co. 2022-10-18 Not applicable US 
Sun Project Skin-relief Suncream Iscotrizinol (0.6 mg/50mL) + Bisoctrizole (1 mg/50mL) + Diethylamino hydroxybenzoyl hexyl benzoate (1.5 mg/50mL) + Octyl triazone (1.2 mg/50mL) Cream Topical Thank You Farmer Co., Ltd. 2022-05-30 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Calming Days Vegan Sunscreen Iscotrizinol (1.2 g/100mL) + Bisoctrizole (2 g/100mL) + Diethylamino hydroxybenzoyl hexyl benzoate (3 g/100mL) + Octyl triazone (2.4 g/100mL) Gel Topical Merci Co. 2022-10-18 Not applicable US Sun Project Skin-relief Suncream Iscotrizinol (0.6 mg/50mL) + Bisoctrizole (1 mg/50mL) + Diethylamino hydroxybenzoyl hexyl benzoate (1.5 mg/50mL) + Octyl triazone (1.2 mg/50mL) Cream Topical Thank You Farmer Co., Ltd. 2022-05-30 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 2UTZ0QC864
- CAS number
- 154702-15-5
- InChI Key
- OSCJHTSDLYVCQC-UHFFFAOYSA-N
- InChI
- InChI=1S/C44H59N7O5/c1-8-12-14-30(10-3)28-55-39(53)33-18-24-36(25-19-33)46-42-48-41(45-35-22-16-32(17-23-35)38(52)51-44(5,6)7)49-43(50-42)47-37-26-20-34(21-27-37)40(54)56-29-31(11-4)15-13-9-2/h16-27,30-31H,8-15,28-29H2,1-7H3,(H,51,52)(H3,45,46,47,48,49,50)
- IUPAC Name
- 2-ethylhexyl 4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzoate
- SMILES
- CCCCC(CC)COC(=O)C1=CC=C(NC2=NC(NC3=CC=C(C=C3)C(=O)OCC(CC)CCCC)=NC(NC3=CC=C(C=C3)C(=O)NC(C)(C)C)=N2)C=C1
References
- General References
- Not Available
- External Links
- ChemSpider
- 7986571
- 2602134
- ChEMBL
- CHEMBL2103813
- Wikipedia
- Iscotrizinol
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Gel Topical Cream Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.000913 mg/mL ALOGPS logP 8.11 ALOGPS logP 12.39 Chemaxon logS -5.9 ALOGPS pKa (Strongest Acidic) 11.35 Chemaxon pKa (Strongest Basic) 3.73 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 9 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 156.46 Å2 Chemaxon Rotatable Bond Count 24 Chemaxon Refractivity 223.95 m3·mol-1 Chemaxon Polarizability 87.63 Å3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 279.8594 predictedDeepCCS 1.0 (2019) [M+H]+ 281.87903 predictedDeepCCS 1.0 (2019) [M+Na]+ 287.61945 predictedDeepCCS 1.0 (2019)
Drug created at August 13, 2019 21:16 / Updated at February 21, 2021 18:55